cannabis hopes drug firm
prescription cannabis drug uk biotech firm gw pharmaceuticals set approved canada
drug treat central nervous system alleviate symptoms multiple sclerosis ms weeks ago shares gw pharma lost uk regulators evidence drug benefits canadian authorities sativex drug considered approval
canada diagnosed ms suffering condition uk patients smoke cannabis relieve symptoms
gw pharma sativex mouth spray legally ms sufferers canada months drug approved representing landmark gw pharma patients final approval canada formality analysts company expects approval sativex delighted receive qualifying notice health canada forward receiving regulatory approval sativex canada gw pharma executive chairman dr geoffrey
uk government granted gw pharma licence grow cannabis plant medical purposes satifex consists cannabis extract tetrahydrocannabinol cannabidiol cocktail proved effective treating patients arthritis thousands plants grown secret location english countryside hopes regulatory approval series delays sativex launch uk news shares gw pharma
